http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Depression and Anxiety Increased Cardiovascular Risk among People Living with HIV/AIDS
박경실,황선영,Choi Bo Youl,Kim June Myung,Kim Sang Il,김우주,강춘 한국역학회 2021 Epidemiology and Health Vol.43 No.-
OBJECTIVES: As HIV/AIDS is becoming a chronic disease, the risk of developing cardiovascular disease (CVD) among people living with HIV/AIDS is rising. Anxiety and depression, which are common among people living with HIV/AIDS, have been linked with CVD. This study investigated the risk of CVD in people living with HIV/AIDS and explored the effects of depression and anxiety on CVD risk. METHODS: Data were collected for 457 people enrolled in the Korea Cohort HIV/AIDS study after 2010. Framingham risk scores were calculated to quantify the 10-year risk of developing CVD. Depression and anxiety variables were re-coded as a single combined variable. Multivariable logistic regression analysis was performed, adjusting for age, body mass index, low-density lipoprotein (LDL) cholesterol, triglycerides (TG), duration of human immunodeficiency virus (HIV) positivity after entry into the cohort, and depression/anxiety. RESULTS: Participants with both depression and anxiety were 2.28 times more likely than those with neither depression nor anxiety to have moderate/high-risk CVD risk. The 10-year risk of developing CVD was affected by LDL cholesterol, TG, age, and duration of HIV infection. LDL cholesterol and TG levels change according to the duration of HIV infection, and metabolic disorders affect the risk of CVD. Thus, a longer duration of HIV infection is associated with a higher risk of developing CVD. CONCLUSIONS: Screenings for depression and anxiety need to be provided regularly to assess the severity of those symptoms. To help decrease their risk of developing CVD, people living with HIV/AIDS should be offered behavioral modification interventions aimed at developing healthy lifestyle habits.
호기성 그람 음성간규 및 그람 양성 구균에 대한 Flomoxef 와 Cefotaxime, Ceftriaxone, Ceftazidime 간의 항균력 비교평가
박경실 대한화학요법학회 1993 대한화학요법학회지 Vol.11 No.2
Flomoxef and the other 3third generation cephalosporins were tested for its anitmicrobial effects. Minimal Inhibitory Concentration of total 258 clinical isolates were determined by the agar dilution method. Flomoxef showed MIC_(90) agaist MSCNS, MRCNS, and MSSA lower than those of cefotaxime, ceftriaxone and ceftazidime. MIC_(90) of flomoxef was the lowest against E.coli, 0.06 ㎍/ml. Against Klebsiella pneumonia, Enterobacter species and Streptococcus species, flomoxef showed the lower MIC_(90) than those of the other three third generation cephalosporins. However, flomoxef showed no difference in MIC_(90) against MRSA, Citrobacter freundii and Serratia species with those of the other cephalosporins. Compared to the other three third generation cephalosporins, flomoxef showed the lowest MIC_(90) against all isolates except. MRSA, Citrobacter freundii and Serratia species. These high active in vitro test results suggest the usefulness of flomoxef for the treatment of Gram-negative bacilli and oxacillim sensitive Gram-positive cocci in the setting of nosocomial infections.